Viewing nowCombinationRivarozet Tablet 2/10 mg
Pitavastatin Calcium Hydrate 2.205mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
JW Pharmaceutical Co., Ltd.

MFDS item code 202105578 · Approved 2021.07.28 · Insurance code 644914960
Improvement of primary hypercholesterolemia and mixed dyslipidemia
This drug helps to lower elevated total cholesterol, LDL cholesterol, Apo B protein, triglyceride, and non-HDL cholesterol levels in patients with primary hypercholesterolemia, especially in heterozygous familial and non-familial patients, and mixed dyslipidemia patients, while increasing good cholesterol HDL cholesterol levels. It also assists in effectively managing cholesterol levels as an adjunct to dietary therapy. Therefore, it is used to improve lipid abnormalities related to cholesterol.
This medicine is administered once daily, regardless of food. Patients must continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. The recommended initial dose is 2/10mg once daily. If the LDL cholesterol-lowering effect is insufficient, the dose may be increased to a maximum of 4/10mg once daily. Adjust the dose as appropriate at intervals of 4 weeks or longer, according to the LDL cholesterol level, treatment goal, and patient response. Patients taking pitavastatin calcium and ezetimibe concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Administration in patients with hepatic impairment: Because an initial dose of 1 milligram once daily is recommended for pitavastatin calcium in patients with hepatic impairment, initiation of treatment with this medicine (pitavastatin calcium/ezetimibe combination) is not recommended. The maximum dose is 2/10mg once daily. Use of this medicine (pitavastatin calcium/ezetimibe combination) is not recommended in patients with moderate hepatic impairment. Do not administer this medicine (pitavastatin calcium/ezetimibe combination) to patients with severe hepatic impairment.
This drug should not be administered to certain patients. For example, patients with allergies to any ingredient in this drug, those with active liver disease, severe liver impairment, bile duct obstruction, those taking cyclosporine, patients with myopathy, pregnant women or those who may become pregnant, nursing mothers, and children should not use this drug. Additionally, it should be used cautiously in patients with slightly decreased liver function, those consuming excessive alcohol, patients with renal impairments, hypothyroidism patients, individuals with genetic muscle diseases or a history of muscle-related issues, elderly individuals, and patients with severe muscle weakness. During the administration of this drug, care should be taken to monitor for adverse reactions. Common symptoms may include headache, abdominal pain, diarrhea, muscle pain, and fatigue; although rare, liver dysfunction, muscle damage, and allergic reactions may occur. In particular, if symptoms such as muscle pain or weakness, changes in urine color appear, consultation with a physician should be sought immediately, as these could be signs of muscle damage or rhabdomyolysis. This drug is metabolized in the liver, so regular liver function tests should be conducted, and it may be necessary to discontinue or adjust the dosage if liver enzyme levels are elevated. Furthermore, this drug may interact with other medications, so those taking cyclosporine, fibrates, niacin, or erythromycin should inform their physician and exercise caution. Pregnant or nursing women should not take this drug, and women planning to become pregnant should consult their physician before use. Safety and efficacy for children have not been established, thus it is not recommended for use in this population. Elderly patients may have an increased likelihood of adverse reactions due to declines in bodily functions, thus dosage adjustments may be necessary if symptoms occur. In case of an overdose, there is no specific antidote, so treatment should be symptomatic, and liver function and muscle enzyme levels should be monitored. Lastly, this drug should be kept out of reach of children and care should be taken to avoid transferring it to another container.
Constipation, abdominal pain, indigestion, nausea, upper respiratory infection, nasopharyngitis, headache, dizziness, abnormal liver enzymes, increased liver enzymes, pruritus, allergic pruritus, muscle spasms, prostate dysplasia, myalgia, weakness, rash, malaise, paralysis, itching, elevated γ-GT, increased plasma creatine phosphokinase levels, elevated serum ALT, elevated serum AST, urticaria, erythema, angioedema, elevated bilirubin, increased cholinesterase, stiffness, drowsiness, insomnia, thirst, abdominal bloating, stomatitis, vomiting, loss of appetite, glossitis, nausea, gastric discomfort, diarrhea, thrombocytopenia, granulocytopenia, leukopenia, eosinophilia, leukocytosis, increased globulin, positive Coombs test, anemia, increased urine output, elevated BUN, increased serum creatinine, decreased aldosterone, increased aldosterone, elevated adrenocorticotropic hormone, increased cortisol, decreased testosterone, muscle cramps, elevated myoglobin, increased CPK, palpitations, fatigue, skin pain, burning sensation, arthralgia, edema, blurred vision, photophobia, hearing loss, hematuria, elevated uric acid levels, increased serum potassium and phosphorus, dysgeusia, discolored urine, hair loss, sleep disturbances, memory loss, depression, interstitial lung disease, sexual dysfunction, diabetes, immune-mediated necrotizing myopathy, severe muscle weakness, ocular myasthenia, facial edema, swelling, arm edema, hypersensitivity, skin paresthesia, insomnia, loss of appetite, increased blood pressure, chest discomfort, weakness, thirst, chest pain, chest discomfort, systemic edema, diabetic neuropathy, tremors, upper abdominal pain, vomiting, gastritis, epigastric discomfort, belching, gastrointestinal disorders, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, cough, sputum, rhinorrhea, limb pain, arthralgia, hypoglycemia, anemia, splenomegaly, hyperhidrosis, conjunctival congestion, kidney failure, liver dysfunction, increased blood creatinine, increased blood urea, abnormal liver function tests, anaphylaxis, rash, angioedema, erythema multiforme, arthralgia, pancreatitis, sensory disturbances, cholelithiasis, cholecystitis
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a container that does not allow light. Additionally, it is best to store the medication at room temperature, between 1°C and 30°C, avoiding excessively hot or cold conditions.
Pink round film-coated tablet
30 tablets/box[(10 tablets/PTP x 3)], 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationPitavastatin Calcium Hydrate 2.205mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
JW Pharmaceutical Co., Ltd.
CombinationPitavastatin Calcium Hydrate 4.409mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
JW Pharmaceutical Corp.
CombinationPitavastatin Calcium 4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Ankuk Pharmaceutical Co., Ltd.
CombinationPitavastatin Calcium 2mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Ahn Gook Pharmaceutical Co., Ltd.
CombinationPitavastatin Calcium 4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Hanlim Pharmaceutical Co., Ltd.
CombinationPitavastatin Calcium 2mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Hanlim Pharmaceutical Co., Ltd.
CombinationPitavastatin Calcium 4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Dongkwang Pharmaceutical Co., Ltd.
CombinationPitavastatin Calcium 2mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Dongkwang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.